Bold Ioan T, Specht Ann-Kathrin, Droste Conrad F, Zielinski Alexandra, Meyer Felix, Clauditz Till S, Münscher Adrian, Werner Stefan, Rothkamm Kai, Petersen Cordula, Borgmann Kerstin
Laboratory of Radiobiology & Experimental Radiooncology, Center of Oncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Cancers (Basel). 2021 Mar 10;13(6):1194. doi: 10.3390/cancers13061194.
Aneuploidy is a consequence of chromosomal instability (CIN) that affects prognosis. Gene expression levels associated with aneuploidy provide insight into the molecular mechanisms underlying CIN. Based on the gene signature whose expression was consistent with functional aneuploidy, the CIN70 score was established. We observed an association of CIN70 score and survival in 519 HNSCC patients in the TCGA dataset; the 15% patients with the lowest CIN70 score showed better survival ( = 0.11), but association was statistically non-significant. This correlated with the expression of 39 proteins of the major repair complexes. A positive association with survival was observed for MSH2, XRCC1, MRE11A, BRCA1, BRCA2, LIG1, DNA2, POLD1, MCM2, RAD54B, claspin, a negative for ERCC1, all related with replication. We hypothesized that expression of these factors leads to protection of replication through efficient repair and determines survival and resistance to therapy. Protein expression differences in HNSCC cell lines did not correlate with cellular sensitivity after treatment. Rather, it was observed that the stability of the DNA replication fork determined resistance, which was dependent on the ATR/CHK1-mediated S-phase signaling cascade. This suggests that it is not the expression of individual DNA repair proteins that causes therapy resistance, but rather a balanced expression and coordinated activation of corresponding signaling cascades.
非整倍体是影响预后的染色体不稳定性(CIN)的结果。与非整倍体相关的基因表达水平为深入了解CIN的分子机制提供了线索。基于其表达与功能性非整倍体一致的基因特征,建立了CIN70评分。我们在TCGA数据集中观察到519例头颈部鳞状细胞癌(HNSCC)患者的CIN70评分与生存率之间的关联;CIN70评分最低的15%患者显示出更好的生存率( = 0.11),但该关联在统计学上无显著意义。这与主要修复复合体的39种蛋白质的表达相关。观察到MSH2、XRCC1、MRE11A、BRCA1、BRCA2、LIG1、DNA2、POLD1、MCM2、RAD54B、claspin与生存率呈正相关,ERCC1呈负相关,所有这些都与复制有关。我们假设这些因子的表达通过有效修复导致对复制的保护,并决定生存和对治疗的抗性。HNSCC细胞系中的蛋白质表达差异与治疗后的细胞敏感性无关。相反,观察到DNA复制叉的稳定性决定抗性,这取决于ATR/CHK1介导的S期信号级联反应。这表明导致治疗抗性的不是单个DNA修复蛋白的表达,而是相应信号级联反应的平衡表达和协同激活。